Evidence map›Paper›PMID 19675169›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis.

Taylor R Dagenais, Bailey E Freeman, Karen P Demick, Donna M Paulnock, John M Mansfield

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Taylor R DagenaisDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Bailey E Freeman
Karen P Demick
Donna M Paulnock
John M Mansfield
University of Wisconsin–Madison · US

Funding

MACROPHAGE ACTIVATION IN AFRICAN TRYPANOSOMIASISR01AI048242 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PAULNOCK, DONNA M · 2002 to 2006
$1.6M
IMMUNOBIOLOGY OF AFRICAN TRYPANOSOMIASISR01AI022441 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI MANSFIELD, JOHN M. · 1985 to 2002
$1.0M
Modulation of innate immunity by microbial factorsR01AI051421 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PAULNOCK, DONNA M · 2002 to 2006
$905k
Novel Immunotherapy of African TrypanosomiasisR21AI073346 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI MANSFIELD, JOHN M. · 2008 to 2009
$404k
Cross-Protective Immunity to African TrypanosomesR21AI092460 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI MANSFIELD, JOHN M. · 2011 to 2012
$401k
NIAID NIH HHS AI-048242NIAID NIH HHS AI-051421NIAID NIH HHS AI-073346NIAID NIH HHS AI-22441NIAID NIH HHS R01 AI022441NIAID NIH HHS R01 AI048242NIAID NIH HHS R01 AI051421NIAID NIH HHS R21 AI073346NIAID NIH HHS R21 AI092460
6 · The paper itself

Abstract

Th1 cell responses to the variant surface glycoprotein (VSG) of African trypanosomes play a critical role in controlling infection through the production of IFN-gamma, but the role of APCs in the induction and regulation of T cell-mediated protection is poorly understood. In this study, we have investigated the Ag presentation capabilities of dendritic cells (DCs) and macrophages during early trypanosome infection in relatively resistant responder and susceptible nonresponder mouse strains. Splenic DCs appeared to be the primary cell responsible for activating naive VSG-specific Th cell responses in resistant responder animals through the coordinated up-regulation of costimulatory molecules, secretion of IL-12, and presentation of VSG peptides to T cells in vivo. Splenic DC depletion and the down-regulation of costimulatory markers on splenic macrophages were observed in susceptible animals and may be associated with the inability of these animals to elicit a significant VSG-specific T cell response. In contrast to splenic APCs, peritoneal macrophages secreted NO, failed to activate naive Th cells in vitro, and presented relatively low levels of VSG peptides to T cells in vivo. Thus, VSG-specific Th1 cell responses may be determined by tissue- and cell-specific differences in Ag presentation. Additionally, all APCs from resistant and susceptible strains displayed a reduced ability to process and present newly encountered exogenous Ag, including new VSG molecules, during high parasitemia. Thus, initial uptake of VSG (or other trypanosome factors) may interfere with Ag presentation and have dramatic consequences for subsequent T cell responses to other proteins.

Indexed as

AnimalsAntigen PresentationCell MembraneCytokinesDendritic CellsFemaleGenetic Predisposition to DiseaseHistocompatibility Antigens Class IIImmunophenotypingMacrophages, PeritonealMiceMice, Inbred C3HMice, Inbred C57BLMice, KnockoutMice, TransgenicTh1 CellsCytokinesHistocompatibility Antigens Class IIVariant Surface Glycoproteins, Trypanosoma

Identifiers

PMID19675169
PMCPMC2730433
OpenAlexW1512520758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.